Logo image of TSRI

TSR INC (TSRI) Stock Fundamental Analysis

USA - NASDAQ:TSRI - US8728852075 - Common Stock

13.38 USD
+0.01 (+0.04%)
Last: 6/28/2024, 8:00:01 PM
13.3584 USD
-0.02 (-0.16%)
After Hours: 6/21/2024, 8:00:02 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TSRI. TSRI was compared to 85 industry peers in the IT Services industry. TSRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TSRI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year TSRI was profitable.
TSRI had a positive operating cash flow in the past year.
In multiple years TSRI reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: TSRI reported negative operating cash flow in multiple years.
TSRI Yearly Net Income VS EBIT VS OCF VS FCFTSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

With a decent Return On Assets value of 7.75%, TSRI is doing good in the industry, outperforming 76.83% of the companies in the same industry.
TSRI's Return On Equity of 10.80% is fine compared to the rest of the industry. TSRI outperforms 71.95% of its industry peers.
TSRI has a better Return On Invested Capital (7.89%) than 68.29% of its industry peers.
TSRI had an Average Return On Invested Capital over the past 3 years of 5.05%. This is significantly below the industry average of 21.61%.
The last Return On Invested Capital (7.89%) for TSRI is above the 3 year average (5.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROIC 7.89%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
TSRI Yearly ROA, ROE, ROICTSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

TSRI's Profit Margin of 2.15% is in line compared to the rest of the industry. TSRI outperforms 56.10% of its industry peers.
TSRI's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 2.34%, TSRI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
TSRI's Operating Margin has improved in the last couple of years.
TSRI has a Gross Margin of 17.57%. This is amonst the worse of the industry: TSRI underperforms 92.68% of its industry peers.
TSRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
TSRI Yearly Profit, Operating, Gross MarginsTSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TSRI is destroying value.
Compared to 1 year ago, TSRI has less shares outstanding
TSRI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for TSRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TSRI Yearly Shares OutstandingTSRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
TSRI Yearly Total Debt VS Total AssetsTSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 8.47 indicates that TSRI is not in any danger for bankruptcy at the moment.
TSRI has a Altman-Z score of 8.47. This is amongst the best in the industry. TSRI outperforms 90.24% of its industry peers.
TSRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.47
ROIC/WACC0.77
WACC10.19%
TSRI Yearly LT Debt VS Equity VS FCFTSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

TSRI has a Current Ratio of 3.37. This indicates that TSRI is financially healthy and has no problem in meeting its short term obligations.
TSRI has a Current ratio of 3.37. This is amongst the best in the industry. TSRI outperforms 81.71% of its industry peers.
A Quick Ratio of 3.37 indicates that TSRI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.37, TSRI belongs to the top of the industry, outperforming 81.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
TSRI Yearly Current Assets VS Current LiabilitesTSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

4

3. Growth

3.1 Past

TSRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.48%, which is quite impressive.
The Earnings Per Share has been growing by 24.57% on average over the past years. This is a very strong growth
TSRI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.51%.
The Revenue has been growing by 9.30% on average over the past years. This is quite good.
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TSRI Yearly Revenue VS EstimatesTSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.56, TSRI is valued correctly.
75.61% of the companies in the same industry are more expensive than TSRI, based on the Price/Earnings ratio.
TSRI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.56
Fwd PE N/A
TSRI Price Earnings VS Forward Price EarningsTSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TSRI is valued cheaply inside the industry as 84.15% of the companies are valued more expensively.
84.15% of the companies in the same industry are more expensive than TSRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 7.99
TSRI Per share dataTSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TSRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TSR INC

NASDAQ:TSRI (6/28/2024, 8:00:01 PM)

After market: 13.3584 -0.02 (-0.16%)

13.38

+0.01 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-10 2024-04-10/amc
Earnings (Next)08-09 2024-08-09/amc
Inst Owners6.6%
Inst Owner Change-43.85%
Ins Owners38.36%
Ins Owner Change0%
Market Cap29.03M
Revenue(TTM)88.82M
Net Income(TTM)1.91M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE N/A
P/S 0.33
P/FCF 13.32
P/OCF 13.32
P/B 1.64
P/tB 1.85
EV/EBITDA 7.99
EPS(TTM)0.86
EY6.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1
FCFY7.51%
OCF(TTM)1
OCFY7.51%
SpS40.93
BVpS8.15
TBVpS7.23
PEG (NY)N/A
PEG (5Y)0.63
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROCE 11.4%
ROIC 7.89%
ROICexc 19.04%
ROICexgc 25.92%
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
FCFM 2.46%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
ROICexc(3y)9.78%
ROICexc(5y)N/A
ROICexgc(3y)13.54%
ROICexgc(5y)N/A
ROCE(3y)7.31%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y1.93%
ROICexc growth 3YN/A
ROICexc growth 5Y-3.61%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
F-Score8
Asset Turnover3.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 250
Cash Conversion 95.05%
Profit Quality 114.1%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 8.47
F-Score8
WACC10.19%
ROIC/WACC0.77
Cap/Depr(3y)40.97%
Cap/Depr(5y)64.58%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.3%
EBIT growth 3YN/A
EBIT growth 5Y24.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y217.24%
FCF growth 3YN/A
FCF growth 5Y9.41%
OCF growth 1Y229.8%
OCF growth 3YN/A
OCF growth 5Y9.14%

TSR INC / TSRI FAQ

Can you provide the ChartMill fundamental rating for TSR INC?

ChartMill assigns a fundamental rating of 5 / 10 to TSRI.


Can you provide the valuation status for TSR INC?

ChartMill assigns a valuation rating of 4 / 10 to TSR INC (TSRI). This can be considered as Fairly Valued.


What is the profitability of TSRI stock?

TSR INC (TSRI) has a profitability rating of 5 / 10.


Can you provide the financial health for TSRI stock?

The financial health rating of TSR INC (TSRI) is 9 / 10.


How sustainable is the dividend of TSR INC (TSRI) stock?

The dividend rating of TSR INC (TSRI) is 0 / 10 and the dividend payout ratio is 0%.